Neuromuscular NGS Assay

Overview


Neuromuscular Disorders: Understanding the Link Between Nerves and Muscle Neuromuscular disorders are a diverse group of conditions that disrupt communication between nerves and muscles, leading to progressive muscle weakness, fatigue, pain, and impaired movement. These disorders affect the muscles, peripheral nervous system, and the pathways that control muscle function. Symptoms can appear anytime from infancy to adulthood and may include difficulty swallowing, balance issues, and loss of muscle tone. Diagnosis relies on advanced techniques such as genetic testing, electromyography, muscle biopsy, and biochemical analysis.

Genetic testing is revolutionizing the diagnosis and treatment of neuromuscular disorders, enabling precise identification of conditions that were once difficult to diagnose based on symptoms alone. From early-onset spinal muscular atrophy where targeted therapies now offer hope to hereditary polyneuropathies and other genetically complex disorders, advanced genetic diagnostics provide clarity in the face of heterogeneity. By uncovering the root cause, genetic insights guide personalized treatment strategies and improve patient outcomes. The Genes2Me Neuromuscular NGS Assay Panel targets key genes linked to a wide spectrum of hereditary conditions including muscular dystrophies, inherited myopathies, spinal muscular atrophies, and more. By delivering accurate genetic insights, this panel empowers healthcare providers to validate clinical diagnoses, anticipate disease outcomes, optimize treatment strategies, and offer informed genetic counselling for families.

Product highlights & key features
Comprehensive Genetic Coverage: Targets 497 clinically relevant genes across the whole coding sequence (1.4 Mb) for complete analysis.
Advanced Mutation Detection: Accurately identifies SNVs, InDels, and CNVs using hybridization based NGS with high sensitivity and specificity.
Shortens the Diagnostic Odyssey: Provides a conclusive molecular diagnosis for genetically heterogeneous neuromuscular conditions, reducing invasive and costly investigations.
Supports Personalized Care: Enables prognosis prediction, early symptom detection, informed family planning, and clinical trial enrollment.
Fast & Convenient: Quick turnaround time with a simple blood sample for minimally invasive testing.

Panel Performance

Features Performance
Coverage uniformity (0.2X) >99%
Reproducibility (%) 97.3
Sensitivity (%) 96.5
On Target Ratio (%) >78

Panel Specifications


Number of Genes: 497
Gene count/family: ~293
Target Size: 1.4 Mb
Covered Regions: Whole CDS
Mutation Types: SNV / InDels / CNV
Sample Type: Blood
Platform Compatibility: Illumina, MGI, Thermo Fisher, Element Biosciences

Ordering Information


Commercial Name Cat No. Pack Size Platform
Neuromuscular NGS Test Kit G710024-1 24 T Illumina
G710024-2 96 T Illumina
G710024-3 96 T – EZY Illumina – EZY
Neuromuscular NGS Test Kit G710024-4 24 T MGI
G710024-5 96 T MGI
G710024-6 96 T – EZY MGI – EZY
Neuromuscular NGS Test Kit G710024-7 24 T Aviti
G710024-8 96 T Aviti
G710024-9 96 T – EZY Aviti – EZY
Neuromuscular NGS Test Kit G710024-10 24 T Thermo
G710024-11 96 T Thermo
G710024-12 96 T – EZY Thermo – EZY

PROCESS WORKFLOW

Neuromuscular workflow

Resources


Download useful documents and technical information for the neuromuscluar NGS Assays.

Product Enquiry Form


Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.


© 2025 Genes2me. All rights reserved.